(no subject)

The Food and Drug Administration is warning consumers today that certain stomach acid drugs may increase the risk of a serious intestinal bacteria infection.

The drugs, including Nexium, Prilosec, Prevacid, Zegerid and others, fall into a category called proton pump inhibitors (PPIs). They are prescribed to treat acid reflux, stomach ulcers and other conditions, and work by reducing the amount of acid in the stomach.
The bacterial illness is called Clostridium difficile–associated diarrhea (CDAD), and its main symptom is diarrhea that does not improve, according to an FDA statement. Patients taking PPIs who develop diarrhea that does not improve may have CDAD, according to the FDA.
There are antibiotics that can be used to treat C. diff, according to the CDC, but in some severe cases, surgery to remove the infected part of the intestines may be needed. 
http://www.npr.org/blogs/health/2012/02/08/146576305/heartburn-treatments-may-lead-to-serious-diarrhea

(no subject)

What did FDA's expanded survey reveal about lipsticks on the market?

The expanded survey found that the average lead concentration in the 400 lipsticks tested was 1.11 ppm, very close to the average of 1.07 ppm obtained in our initial survey. The results ranged from the detection limit of 0.026 ppm to the highest value of 7.19 ppm. For a table of the results, see FDA Analyses of Lead in Lipsticks – Expanded Survey. The expanded survey will be published in the May/June, 2012, issue of the Journal of Cosmetic Science.

http://www.fda.gov/Cosmetics/ProductandIngredientSafety/ProductInformation/ucm137224.htm#expanalyses%20